GenScript USA Revenue and Competitors

Location

$11.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • GenScript USA's estimated annual revenue is currently $269.1M per year.(i)
  • GenScript USA's estimated revenue per employee is $248,000
  • GenScript USA's total funding is $11.2M.

Employee Data

  • GenScript USA has 1085 Employees.(i)
  • GenScript USA grew their employee count by 8% last year.

GenScript USA's People

NameTitleEmail/Phone
1
General Counsel & VP for Corporate DevelopmentReveal Email/Phone
2
Head BD TeamReveal Email/Phone
3
Head Marketing & Sales, Catalog Products Business UnitReveal Email/Phone
4
Head Segment Marketing, Life Science GroupReveal Email/Phone
5
VP, Business Development, Biosciences GroupReveal Email/Phone
6
Head Project ManagementReveal Email/Phone
7
Head Information Technology Services US SiteReveal Email/Phone
8
VP, Innovation CenterReveal Email/Phone
9
VP Corporate Development & StrategyReveal Email/Phone
10
Head LogisticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$132.3M1286-3%$503.1M$3B
Add Company

What Is GenScript USA?

GenScript is a leading biology CRO focusing exclusively on early drug discovery and development services. Built on our assembly-line mode, one-stop solution, continuous improvement, and stringent IP protection, GenScript provides a comprehensive portfolio of services that include Bio-Reagent, Bio-Assay, Lead Optimization, and Antibody Drug Development which can be effectively integrated into your value chain and your operations. We strive with competence and confidence to meet your demand for developing pre-clinical drug candidates time-efficiently and cost-effectively. With track performance record, GenScript is your ideal and reliable innovation partner in drug discovery.

keywords:N/A

$11.2M

Total Funding

1085

Number of Employees

$269.1M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GenScript USA News

2022-04-19 - Biologics Drug Discovery Market Size, Outlook And Forecast ...

New Jersey, United States – The Biologics Drug Discovery Market research report ... GenScript, Roche, Pfizer, Novartis, Sanofi, Merck, GlaxoSmithKline,...

2022-04-13 - Global Gene Editing Market Analysis 2022-2026, Featuring ...

GenScript USA Inc. Horizon Discovery Group plc; Integrated DNA Technologies; New England Biolabs; OriGene Technologies; Thermo Fisher Scientific...

2022-04-06 - GenScript Debuts Industry's Highest Throughput DNA ...

Each CMOS DNA chip carries 8.4 million unique oligos. OAKLAND, Calif. and PISCATAWAY, N.J., April 13, 2022 /PRNewswire/ -- GenScript USA...

2021-11-12 - GenScript Launches Closed-End Double-Stranded DNA Service for CRISPR

PISCATAWAY, N.J., Nov. 12, 2021 /PRNewswire/ -- GenScript USA Inc., the world's leading life science research tools and services provider, announced today that it has launched the GenWand™ Double-Stranded DNA (dsDNA) Service for the manufacture of CRISPR knock-in homology- directed repair (HDR) ...

2021-11-02 - GenScript Expands Commercial Production in U.S. with State-of-the-Art Gene Synthesis Center

PISCATAWAY, New Jersey, Nov. 2, 2021 /PRNewswire/ -- GenScript USA Inc., the world's leading life science research tools and services provider, announced today that it has opened a larger than 50,000-square-foot facility for highly automated gene synthesis and plasmid preparation services near i ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$750M14388%N/A
#2
$75M184826%N/A
#3
$405.2M1996N/AN/A
#4
$482.7M2463N/AN/A
#5
$6072.2M163678%N/A